We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORIQ:NASDAQOrigin Investment Corp I Analysis

Data as of 2026-05-19 - not real-time

$10.28

Latest Price

8/10Risk

Risk Level: High

Executive Summary

ORIQ is trading at $10.28, just below its 30‑day resistance of $10.28 and above the identified support of $10.20. The 20‑day, 50‑day and 200‑day simple moving averages are tightly clustered at $10.24, $10.22 and $10.16, indicating a narrow price corridor and strong short‑term momentum. Momentum indicators are bullish: the RSI sits at 67, the MACD line is above its signal line, and the histogram is positive, while volume is trending upward. However, the 30‑day volatility is modest at 1.65 % and beta is essentially neutral (‑0.01), suggesting limited price swing potential. The market sentiment gauge reads Extreme Greed (89.09 on the Fear & Greed Index), which often precedes a short‑term pull‑back in over‑bought environments.
Fundamentally, ORIQ is a shell with zero revenue, negative operating cash flow, and a trailing EPS of $0.17, resulting in a trailing P/E of 60.5 versus an industry average of 16.6. The price‑to‑book ratio of 85.7 and a book value per share of $0.12 further underscore the disconnect between market price and underlying assets. The company holds roughly $1.15 million in cash and no debt, but its free cash flow of –$170 k and ROE of just 1.2 % provide little cushion for future value creation. With a market cap of $88.7 million and daily volume averaging only 600 shares against a 10‑day average of over 42,000, liquidity is a significant concern. Given the speculative nature of its merger‑focused strategy and the absence of operating earnings, the stock appears substantially overvalued and carries elevated risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and RSI indicate short‑term momentum
  • Price is near support level offering downside cushion
  • Lack of earnings and high valuation limit upside

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Trailing P/E of 60.5 far exceeds industry average
  • Price‑to‑book of 85.7 shows extreme overvaluation
  • Liquidity constraints with low daily volume

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • No operating revenue or cash‑flow generation
  • Speculative merger‑driven business model
  • High valuation multiples with minimal asset base

Key Metrics & Analysis

Financial Health

P/E Ratio60.5
ROE124.00%
ROA-1.17%
P/B Ratio85.7
Op. Cash Flow$-694714
Free Cash Flow$-170455
Industry P/E16.6

Technical Analysis

TrendBullish
RSI67.1
Support$10.20
Resistance$10.28
MA 20$10.24
MA 50$10.22
MA 200$10.16
MACDBullish
VolumeIncreasing
Fear & Greed Index89.09

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta-0.01
Volatility1.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.